Ammar A Hasnie1, Usman A Hasnie2, Nirav Patel2,3, Muhammad U Aziz4, Min Xie2,3, Steven G Lloyd2,3,5, Sumanth D Prabhu2,3,5. 1. Department of Internal Medicine, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, BDB 327, Birmingham, AL, 35233, USA. ammarhasnie@uabmc.edu. 2. Department of Internal Medicine, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, BDB 327, Birmingham, AL, 35233, USA. 3. Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA.
Abstract
BACKGROUND: Half of U.S. adults have received at least one dose of the COVID-19 vaccines produced by either Pfizer, Moderna, or Johnson and Johnson, which represents a major milestone in the ongoing pandemic. Given the emergency use authorizations for these vaccines, their side effects and safety were assessed over a compressed time period. Hence, ongoing monitoring for vaccine-related adverse events is imperative for a full understanding and delineation of their safety profile. CASE PRESENTATION: An 22-year-old Caucasian male presented to our hospital center complaining of pleuritic chest pain. Six months prior he had a mild case of COVID-19, but was otherwise healthy. He had received his first dose of the Moderna vaccine three days prior to developing symptoms. Laboratory analysis revealed a markedly elevated troponin and multiple imaging modalities during his hospitalization found evidence of wall motion abnormalities consistent with a diagnosis of perimyocarditis. He was started on aspirin and colchicine with marked improvement of his symptoms prior to discharge. CONCLUSIONS: We present a case of perimyocarditis that was temporally related to COVID-19 mRNA vaccination in an young male with prior COVID-19 infection but otherwise healthy. Our case report highlights an albeit rare but important adverse event for clinicians to be aware of. It also suggests a possible mechanism for the development of myocardial injury in our patient.
BACKGROUND: Half of U.S. adults have received at least one dose of the COVID-19 vaccines produced by either Pfizer, Moderna, or Johnson and Johnson, which represents a major milestone in the ongoing pandemic. Given the emergency use authorizations for these vaccines, their side effects and safety were assessed over a compressed time period. Hence, ongoing monitoring for vaccine-related adverse events is imperative for a full understanding and delineation of their safety profile. CASE PRESENTATION: An 22-year-old Caucasian male presented to our hospital center complaining of pleuritic chest pain. Six months prior he had a mild case of COVID-19, but was otherwise healthy. He had received his first dose of the Moderna vaccine three days prior to developing symptoms. Laboratory analysis revealed a markedly elevated troponin and multiple imaging modalities during his hospitalization found evidence of wall motion abnormalities consistent with a diagnosis of perimyocarditis. He was started on aspirin and colchicine with marked improvement of his symptoms prior to discharge. CONCLUSIONS: We present a case of perimyocarditis that was temporally related to COVID-19 mRNA vaccination in an young male with prior COVID-19infection but otherwise healthy. Our case report highlights an albeit rare but important adverse event for clinicians to be aware of. It also suggests a possible mechanism for the development of myocardial injury in our patient.
Authors: Dimitri C Cassimatis; J Edwin Atwood; Renata M Engler; Peter E Linz; John D Grabenstein; Marina N Vernalis Journal: J Am Coll Cardiol Date: 2004-05-05 Impact factor: 24.094
Authors: Jeffrey S Halsell; James R Riddle; J Edwin Atwood; Pierce Gardner; Robert Shope; Gregory A Poland; Gregory C Gray; Stephen Ostroff; Robert E Eckart; Duane R Hospenthal; Roger L Gibson; John D Grabenstein; Mark K Arness; David N Tornberg Journal: JAMA Date: 2003-06-25 Impact factor: 56.272
Authors: Bhurint Siripanthong; Saman Nazarian; Daniele Muser; Rajat Deo; Pasquale Santangeli; Mohammed Y Khanji; Leslie T Cooper; C Anwar A Chahal Journal: Heart Rhythm Date: 2020-05-05 Impact factor: 6.343
Authors: Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks Journal: N Engl J Med Date: 2020-12-30 Impact factor: 91.245
Authors: Han W Kim; Elizabeth R Jenista; David C Wendell; Clerio F Azevedo; Michael J Campbell; Stephen N Darty; Michele A Parker; Raymond J Kim Journal: JAMA Cardiol Date: 2021-10-01 Impact factor: 30.154
Authors: Jay Montgomery; Margaret Ryan; Renata Engler; Donna Hoffman; Bruce McClenathan; Limone Collins; David Loran; David Hrncir; Kelsie Herring; Michael Platzer; Nehkonti Adams; Aliye Sanou; Leslie T Cooper Journal: JAMA Cardiol Date: 2021-10-01 Impact factor: 30.154
Authors: Cristina Basso; Ornella Leone; Stefania Rizzo; Monica De Gaspari; Allard C van der Wal; Marie-Christine Aubry; Melanie C Bois; Peter T Lin; Joseph J Maleszewski; James R Stone Journal: Eur Heart J Date: 2020-10-14 Impact factor: 29.983
Authors: Florian Krammer; Komal Srivastava; Hala Alshammary; Angela A Amoako; Mahmoud H Awawda; Katherine F Beach; Maria C Bermúdez-González; Dominika A Bielak; Juan M Carreño; Rachel L Chernet; Lily Q Eaker; Emily D Ferreri; Daniel L Floda; Charles R Gleason; Joshua Z Hamburger; Kaijun Jiang; Giulio Kleiner; Denise Jurczyszak; Julia C Matthews; Wanni A Mendez; Ismail Nabeel; Lubbertus C F Mulder; Ariel J Raskin; Kayla T Russo; Ashley-Beathrese T Salimbangon; Miti Saksena; Amber S Shin; Gagandeep Singh; Levy A Sominsky; Daniel Stadlbauer; Ania Wajnberg; Viviana Simon Journal: N Engl J Med Date: 2021-03-10 Impact factor: 91.245
Authors: Maurish Fatima; Huzaifa Ahmad Cheema; Muhammad Huzaifa Ahmed Khan; Hafsa Shahid; Muhammad Saad Ali; Umer Hassan; Muhammad Wahaj Murad; Muhammad Aemaz Ur Rehman; Hareem Farooq Journal: Ann Med Surg (Lond) Date: 2022-03-11
Authors: Benjamin J Behers; Genevieve A Patrick; Jared M Jones; Rachel A Carr; Brett M Behers; Julian Melchor; Delaney E Rahl; Timothy D Guerriero; Hongyu Zhang; Cuneyt Ozkardes; Nicholas D Thomas; Michael J Sweeney Journal: Yale J Biol Med Date: 2022-06-30
Authors: Wongi Woo; Ah Y Kim; Dong K Yon; Seung W Lee; Jimin Hwang; Louis Jacob; Ai Koyanagi; Min S Kim; Duk H Moon; Jo W Jung; Jae Y Choi; Se Y Jung; Lucy Y Eun; Sungsoo Lee; Jae Il Shin; Lee Smith Journal: J Med Virol Date: 2021-12-14 Impact factor: 20.693
Authors: Russel J Reiter; Ramaswamy Sharma; Fedor Simko; Alberto Dominguez-Rodriguez; Jan Tesarik; Richard L Neel; Andrzej T Slominski; Konrad Kleszczynski; Verna M Martin-Gimenez; Walter Manucha; Daniel P Cardinali Journal: Cell Mol Life Sci Date: 2022-02-20 Impact factor: 9.207
Authors: Yhojan Rodríguez; Manuel Rojas; Santiago Beltrán; Fernando Polo; Laura Camacho-Domínguez; Samuel David Morales; M Eric Gershwin; Juan-Manuel Anaya Journal: J Autoimmun Date: 2022-08-24 Impact factor: 14.511